- Home
- NNVC vs CASI Comparison
NNVC vs CASI Comparison
Compare NNVC & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNVC | CASI |
|---|---|---|
| Founded | 2005 | 1991 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.8M | 19.7M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | NNVC | CASI |
|---|---|---|
| Price | $1.03 | $0.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 289.0K | 26.1K |
| Earning Date | 02-13-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $26,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $0.85 | $0.74 |
| 52 Week High | $2.23 | $3.09 |
Technical Indicators
Market Signals| Indicator | NNVC | CASI |
|---|---|---|
| Relative Strength Index (RSI) | 46.13 | 38.96 |
| Support Level | $0.93 | $0.74 |
| Resistance Level | $1.05 | $0.97 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 65.22 | 19.74 |
Price Performance
Historical ComparisonAbout NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.